Literature DB >> 16645320

Trends in risk of stroke in patients with a hospital diagnosis of nonvalvular atrial fibrillation: National Cohort Study in Denmark, 1980-2002.

Lars Frost1, Ljubica Vukelic Andersen, Peter Vestergaard, Steen Husted, Leif Spange Mortensen.   

Abstract

AIM: We examined trends in incidence of stroke of any nature (ischemic and/or hemorrhagic) in subjects with a hospital diagnosis of nonvalvular atrial fibrillation or flutter in Denmark from 1980 to 2002 by sex, age and conditions of comorbidity.
METHODS: We identified all individuals, aged 40-89 years, with an incident hospital diagnosis of atrial fibrillation or flutter and no history of stroke or heart valve disease in the Danish National Registry of Patients, and subjects were followed in the Danish National Registry of Patients for occurrence of an incident diagnosis of stroke of any nature (ischemic and/or hemorrhagic) and in the Danish Civil Registration System (emigration and vital status). We used multivariate Cox proportional hazard regression analysis to estimate trends in incidence of stroke.
RESULTS: Nonvalvular atrial fibrillation or flutter was diagnosed in 141,493 subjects (75,126 men and 66,367 women), and during follow-up 15,964 subjects had an incident diagnosis of stroke. The hazard ratios for stroke in the last 3-year period compared to the first 5-year period, adjusted for 10-year age group, conditions of comorbidity, and general stroke trend in the Danish population were 0.78 (95% CI 0.70-0.86) in men, and 0.80 (95% CI 0.72-0.88) in women. The reduction in risk of stroke by calendar year was most prominent in patients aged 40-74 years.
CONCLUSION: We observed a modest decrease in risk of stroke in subject with atrial fibrillation in Denmark during calendar years 1980-2002. However, we could not control for any changes in diagnostic performance, admission practice, and medical management of patients with atrial fibrillation. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16645320     DOI: 10.1159/000092795

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  8 in total

1.  Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Authors:  Kevin E Chan; J Michael Lazarus; Ravi Thadhani; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

2.  Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation.

Authors:  Moti Haim; Moshe Hoshen; Orna Reges; Yardena Rabi; Ran Balicer; Morton Leibowitz
Journal:  J Am Heart Assoc       Date:  2015-01-21       Impact factor: 5.501

3.  No Decline in the Risk of Stroke Following Incident Atrial Fibrillation Since 2000 in the Community: A Concerning Trend.

Authors:  Alanna M Chamberlain; Robert D Brown; Alvaro Alonso; Bernard J Gersh; Jill M Killian; Susan A Weston; Véronique L Roger
Journal:  J Am Heart Assoc       Date:  2016-06-13       Impact factor: 5.501

4.  Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort.

Authors:  Mi Kyoung Son; Nam-Kyoo Lim; Hyung Woo Kim; Hyun-Young Park
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

5.  New-onset atrial fibrillation is a predictor of subsequent hyperthyroidism: a nationwide cohort study.

Authors:  Christian Selmer; Morten Lock Hansen; Jonas Bjerring Olesen; Charlotte Mérie; Jesper Lindhardsen; Anne-Marie Schjerning Olsen; Jesper Clausager Madsen; Ulla Schmidt; Jens Faber; Peter Riis Hansen; Ole Dyg Pedersen; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

6.  Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study.

Authors:  Rikke Sørensen; Gunnar Gislason; Christian Torp-Pedersen; Jonas Bjerring Olesen; Emil L Fosbøl; Morten W Hvidtfeldt; Deniz Karasoy; Morten Lamberts; Mette Charlot; Lars Køber; Peter Weeke; Gregory Y H Lip; Morten Lock Hansen
Journal:  BMJ Open       Date:  2013-05-03       Impact factor: 2.692

7.  Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes.

Authors:  Arlene M Gallagher; Tjeerd P van Staa; Tarita Murray-Thomas; Nils Schoof; Andreas Clemens; Diana Ackermann; Dorothee B Bartels
Journal:  BMJ Open       Date:  2014-01-27       Impact factor: 2.692

8.  Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011.

Authors:  Peter Wæde Hansen; Thomas S G Sehested; Emil Loldrup Fosbøl; Christian Torp-Pedersen; Lars Køber; Charlotte Andersson; Gunnar H Gislason
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.